David Schlotterbeck
 
 
 

David Schlotterbeck

David Schlotterbeck
Chairman and Chief Executive Officer
Aperio Technologies

David Schlotterbeck has been in the medical device industry for the past 22 years.  His focus from the beginning was on patient safety, initially focused on pulse oximetry to reduce patient deaths from anesthesia.  Starting in 1999 he began a focus on improving the safe delivery of intravenous drugs while President and CEO of Alaris Medical Systems.  After being acquired by Cardinal Health in 2004, as Vice Chairman, he expanded his focus on hospital medication safety, offering an extensive portfolio to address all aspects of the hospital medication delivery process.  In 2006, Schlotterbeck redoubled his efforts with a new focus on the prevention of healthcare associated infections in hospitals.  He invested over $2bb in research and acquisitions to build the most comprehensive global portfolio in infection prevention.  In 2008, Cardinal Health shareholders insisted the medical device businesses be separated from Cardinal to better recognize shareholder value.  Schlotterbeck served as Chairman and Chief Executive Officer of CareFusion, the fifth largest global medical technology company spun-out of from Cardinal Health in September 2009 until his retirement in February 2011. Mr. Schlotterbeck returned from retirement as Chairman and CEO of Aperio, an e-Pathology company to bring yet another new technology to healthcare.  He is a graduate of the General Motor Institute with a bachelor’s of science degree in electrical engineering and a master’s of science degree in electrical engineering from Purdue University. Mr. Schlotterbeck also serves as a member of the board of directors of Juniper Networks and Aperio Technologies since 2009.